CD4+CD25+调节性T细胞与转化生长因子-β在口服耐受中的互补作用。
Complementary role of CD4+CD25+ regulatory T cells and TGF-beta in oral tolerance.
作者信息
Chung Yeonseok, Lee Seung-Ho, Kim Dong-Hyeon, Kang Chang-Yuil
机构信息
Laboratory of Immunology, Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Korea.
出版信息
J Leukoc Biol. 2005 Jun;77(6):906-13. doi: 10.1189/jlb.1004599. Epub 2005 Mar 9.
CD4(+)CD25(+) regulatory T cells are thought to be generated in the periphery as well as in the thymus. We sought to determine the roles played by CD4(+)CD25(+) T cells and transforming growth factor-beta (TGF-beta) in the induction and maintenance of tolerance generated by oral antigens in BALB/c mice. We found that oral administration of a high dose of ovalbumin (OVA) suppressed OVA-specific proliferation and antibody production in BALB/c mice depleted of CD25(+) cells. In contrast, the unresponsiveness induced by lower doses of OVA was only partially blocked by CD25 depletion prior to feeding. Depletion of CD4(+)CD25(+) cells after mice were orally tolerized did not reverse the tolerant status, indicating that these cells were not required to maintain the established tolerance. Furthermore, the induction of oral tolerance was not hampered by the administration of TGF-beta-neutralizing antibodies. However, in mice depleted of CD25(+) cells, anti-TGF-beta-neutralizing antibodies blocked the induction of tolerance, regardless of whether the mice followed the high- or low-dose regimens of oral OVA. CD25 depletion together with TGF-beta neutralization led the expansion of OVA-specific CD4 T cells against the subsequent antigen challenge, and each treatment alone did not. Our findings indicate that CD4(+)CD25(+) T cells and TGF-beta play a complementary role in the induction of oral tolerance, at least in part, by regulating the expansion of antigen-specific CD4 T cells.
CD4(+)CD25(+)调节性T细胞被认为在外周以及胸腺中产生。我们试图确定CD4(+)CD25(+) T细胞和转化生长因子-β(TGF-β)在BALB/c小鼠口服抗原诱导和维持耐受性中所起的作用。我们发现,口服高剂量卵清蛋白(OVA)可抑制CD25(+)细胞耗竭的BALB/c小鼠中OVA特异性增殖和抗体产生。相比之下,低剂量OVA诱导的无反应性在喂食前仅被CD25耗竭部分阻断。小鼠口服耐受后CD4(+)CD25(+)细胞的耗竭并未逆转耐受状态,表明维持已建立的耐受性不需要这些细胞。此外,TGF-β中和抗体的给药并未阻碍口服耐受性的诱导。然而,在CD25(+)细胞耗竭的小鼠中,抗TGF-β中和抗体阻断了耐受性的诱导,无论小鼠采用高剂量还是低剂量口服OVA方案。CD25耗竭与TGF-β中和共同导致OVA特异性CD4 T细胞针对随后的抗原攻击发生扩增,而单独的每种处理均未导致这种情况。我们的研究结果表明,CD4(+)CD25(+) T细胞和TGF-β在口服耐受性的诱导中至少部分通过调节抗原特异性CD4 T细胞的扩增发挥互补作用。